Streetbeat News

TVGN

Tevogen Bio Holdings Inc.

Industry

Biotechnology

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.

Open

1.12

Mkt cap

205M

Volume

202K

High

1.18

P/E Ratio

3.34

52-wk high

6.25

Low

1.12

Div yield

N/A

52-wk low

0.26

The article highlights the performance of 12 health care stocks during Friday's after-market session. Notable gainers include Anitra (AZTR), Scinai Immunotherapeutics (SCNI), and Salarius Pharmaceuticals (SLRX), while significant losers include Aethlon Medical (AEMD), Sunshine Biopharma (SBFM), and Tevogen Bio Holdings (TVGN).

Portfolio Pulse from Benzinga Insights

June 07, 2024 | 8:31 pm

The article highlights the performance of 12 health care stocks during Thursday's after-market session. Notable gainers include Venus Concept (VERO), Cyclacel Pharmaceuticals (CYCC), and Applied DNA Sciences (APDN). Significant losers include Biomea Fusion (BMEA), Tevogen Bio Holdings (TVGN), and Bright Green (BGXX).

Portfolio Pulse from Benzinga Insights

June 06, 2024 | 8:31 pm

Tevogen Bio Holdings Inc. (NASDAQ:TVGN) announced that its investigational immunotherapy, TVGN 489, remains effective against the dominant FLiRT strains of SARS-CoV-2. This therapy targets multiple SARS-CoV-2 proteins and retains 95% activity against these variants, including the current dominant strain, KP.2.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 7:54 pm

Tevogen Bio Holdings (NASDAQ:TVGN) reported a Q1 EPS of $(0.26), which is the same as the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:11 pm

Shares of Larimar Therapeutics (NASDAQ:LRMR) surged 17.6% in pre-market trading after the FDA lifted a partial clinical hold on its nomlabofusp clinical program. Other notable pre-market movers include Edible Garden AG (NASDAQ:EDBL) up 94.5%, MGO Global (NASDAQ:MGOL) up 83.6%, and Meta Materials (NASDAQ:MMAT) up 59.1%. On the downside, Greenwave Technology Solutions (NASDAQ:GWAV) fell 59.2%, Rubicon Technologies (NYSE:RBT) dropped 24.1%, and Palo Alto Networks (NASDAQ:PANW) declined 7.9% despite better-than-expected earnings.

Portfolio Pulse from Avi Kapoor

May 21, 2024 | 12:12 pm

The article highlights the pre-market movements of 12 health care stocks on Tuesday. Notable gainers include Biodexa Pharmaceuticals (BDRX), Durect (DRRX), Larimar Therapeutics (LRMR), Tevogen Bio Holdings (TVGN), Envoy Medical (COCH), and Citius Pharma (CTXR). Significant losers include Scorpius Holdings (SCPX), Orgenesis (ORGS), SINTX Techs (SINT), Kazia Therapeutics (KZIA), NovaBay Pharmaceuticals (NBY), and Akanda (AKAN).

Portfolio Pulse from Benzinga Insights

May 21, 2024 | 12:06 pm

Akoustis Technologies shares fell by around 18% due to weak quarterly results, missing both earnings and sales estimates. Other stocks moved significantly in Monday's mid-day session, with notable gainers including GameStop, KOSS Corp, and CareCloud, among others, while losers included Barnes & Noble Education and Seritage Growth Properties.

Portfolio Pulse from Avi Kapoor

May 13, 2024 | 5:01 pm

GameStop, AC Immune, and Tevogen Bio Holdings saw significant stock price movements due to various factors. GME rose amid retail investor interest sparked by Roaring Kitty. ACIU surged after Q1 financial results and a deal with Takeda for Alzheimer's treatment. TVGN climbed following a financing agreement for up to $50 million.

Portfolio Pulse from ryanfaloona@benzinga.com

May 13, 2024 | 12:42 pm

In Monday's pre-market session, several healthcare stocks showed significant movement. Tevogen Bio Holdings led the gainers with a 55.4% increase, while Applied DNA Sciences experienced the largest drop among the losers at 13.1%. Earnings reports were a common factor influencing stock movements, with companies like Dynatronics, Tarsus Pharmaceuticals, Fulcrum Therapeutics, and Fortrea Holdings recently releasing their financial results.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 12:06 pm

JanOne Inc. shares surged 19% in pre-market trading following the announcement of its plans to acquire ALT 5 Sigma Inc. Other stocks also showed significant movement in pre-market trading, with Tevogen Bio Holdings, Nauticus Robotics, GameStop Corp., and KOSS Corp among the gainers. Conversely, Barnes & Noble Education, Seritage Growth Properties, and Applied DNA Sciences were among the notable losers.

Portfolio Pulse from Avi Kapoor

May 13, 2024 | 9:46 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.